Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Phase II trial of individualized/dynamic cisplatin regimens for definitive concurrent chemoradiation therapy in patients with head and neck squamous cell carcinoma

Published:2020-10-19 Issue:24 Volume:9 Page:9256-9265
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med.

Author:

Ahn Dongbin¹^ORCID,Lee Gil Joon¹,Sohn Jin Ho¹,Lee Jeong Eun²

Affiliation:

1. Department of Otolaryngology‐Head and Neck Surgery School of Medicine Kyungpook National University Daegu Korea

2. Department of Radiation Oncology School of Medicine Kyungpook National University Daegu Korea

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3529

Reference26 articles.

1. Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

2. Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

3. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

4. Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer

5. Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of prehydration solution on hearing threshold after chemotherapy in patients with head and neck cancers: a retrospective study;Journal of Yeungnam Medical Science;2023-04-30

2. Nonsurgical Treatment Strategies for Elderly Head and Neck Cancer Patients: An Emerging Subject Worldwide;Cancers;2022-11-19

3. Primary concurrent chemoradiation therapy with triweekly cisplatin as a standard protocol in patients aged ≥65 years with head and neck squamous cell carcinoma;Asia-Pacific Journal of Clinical Oncology;2022-09-30

4. Mefenamic acid as a promising therapeutic medicine against colon cancer in tumor-bearing mice;Medical Oncology;2022-01-04

5. Postoperative Radiochemotherapy Using Modern Radiotherapy Techniques in Elderly Patients with Head and Neck Squamous Cell Carcinoma: The Challenge of Weighing Up Benefits and Harms of Treatment Modalities in Clinical Practice;Cancers;2021-07-06